NCT01170806View on ClinicalTrials.gov

Study of Fat Malabsorption by Lipiblock Versus Xenical

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions
Obesity
Interventions
DRUG

Orlistat

Capsules of 120mg of two commercial formulations of Orlistat (Lipiblock or Xenical) were taken 3 times daily for 7 dayy

Trial Locations (1)

13083-878

LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/University of Campinas (UNICAMP), Campinas

Sponsors

Collaborators (1)

Germed Pharma
All Listed Sponsors
collaborator

Germed Pharma

INDUSTRY

lead

University of Campinas, Brazil

OTHER